Head-to-head · WeighScore
REMEVi vs Welling Health
The verdict
REMEVi takes it — 73.5/100 to 68.3/100.
REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | REMEVi | Welling Health |
|---|---|---|
| WeighScore | 73.5/100 | 68.3/100 |
| Grade | C | C |
| Scorecard rank | #70 | #149 |
| Semaglutide | $219/mo | $190/mo (compounded) |
| Tirzepatide | $319/mo | $275/mo (compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #70 · C
Strengths
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
- Available in all 50 states and DC, with no minimum commitment and no cancellation fee
Where it loses points
- The flat rate is the highest entry price of the top-scoring programmes here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #149 · C
Strengths
- Transparent flat monthly rate — $190 semaglutide / $275 tirzepatide, all doses, no insurance or hidden fees
- LegitScript-certified 503A pharmacy with US-licensed clinicians in all 50 states and a named legal entity
- Streak discounts cut up to 30% — semaglutide as low as $133/month for logging meals consistently
- Free shipping, free AI macro-tracker app, and 24-hour intake review
Where it loses points
- Tirzepatide at $275/month is higher than the cheapest compounded competitors
- The streak discount requires daily in-app meal logging — miss days and you pay full rate
- The compounding pharmacy partner is described as a LegitScript-certified 503A but not named
- Only two medications — compounded semaglutide and tirzepatide; no oral or non-GLP options
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.